Global Gastrointestinal Cancer Drugs Market Analysis 2016-2020 and Forecast 2021-2026

  • Report ID:86887
  • Industry Name: Life & Medical
  • Publishing Date: Apr-21
  • No. of Pages: 86
                              
Snapshot The global Gastrointestinal Cancer Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Gastrointestinal Cancer Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): Oncology Radiology Others Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.): Amgen Limited & Amgen Ireland Limited Bristol-Myers Squibb Company F. Hoffmann-La Roche Ltd. Eli Lilly and Company Johnson & Johnson Private Limited GlaxoSmithKline plc. Celgene Corporation Pfizer Inc. Sanofi Novartis AG Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.): Hospitals Specialized Cancer Treatment Centers Clinics Ambulatory Surgical Centers Region Coverage (Regional Production, Demand & Forecast by Countries etc.): North America (U.S., Canada, Mexico) Europe (Germany, U.K., France, Italy, Russia, Spain etc.) Asia-Pacific (China, India, Japan, Southeast Asia etc.) South America (Brazil, Argentina etc.) Middle East & Africa (Saudi Arabia, South Africa etc.)
                        
Table of Contents Table of Contents 1 Industry Overview 1.1 Gastrointestinal Cancer Drugs Industry Figure Gastrointestinal Cancer Drugs Industry Chain Structure 1.1.1 Overview 1.1.2 Development of Gastrointestinal Cancer Drugs 1.2 Market Segment 1.2.1 Upstream Table Upstream Segment of Gastrointestinal Cancer Drugs 1.2.2 Downstream Table Application Segment of Gastrointestinal Cancer Drugs Table Global Gastrointestinal Cancer Drugs Market 2016-2026, by Application, in USD Million 1.2.3 COVID-19 Impact 1.3 Cost Analysis 2 Industry Environment (PEST Analysis) 2.1 Policy 2.2 Economics 2.3 Sociology 2.4 Technology 3 Gastrointestinal Cancer Drugs Market by Type 3.1 By Type 3.1.1 Oncology Table Major Company List of Oncology 3.1.2 Radiology Table Major Company List of Radiology 3.1.3 Others Table Major Company List of Others 3.2 Market Size Table Global Gastrointestinal Cancer Drugs Market 2016-2020, by Type, in USD Million Figure Global Gastrointestinal Cancer Drugs Market Growth 2016-2020, by Type, in USD Million Table Global Gastrointestinal Cancer Drugs Market 2016-2020, by Type, in Volume Figure Global Gastrointestinal Cancer Drugs Market Growth 2016-2020, by Type, in Volume 3.3 Market Forecast Table Global Gastrointestinal Cancer Drugs Market Forecast 2021-2026, by Type, in USD Million Table Global Gastrointestinal Cancer Drugs Market Forecast 2021-2026, by Type, in Volume 4 Major Companies List 4.1 Amgen Limited & Amgen Ireland Limited (Company Profile, Sales Data etc.) 4.1.1 Amgen Limited & Amgen Ireland Limited Profile Table Amgen Limited & Amgen Ireland Limited Overview List 4.1.2 Amgen Limited & Amgen Ireland Limited Products & Services 4.1.3 Amgen Limited & Amgen Ireland Limited Business Operation Conditions Table Business Operation of Amgen Limited & Amgen Ireland Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.2 Bristol-Myers Squibb Company (Company Profile, Sales Data etc.) 4.2.1 Bristol-Myers Squibb Company Profile Table Bristol-Myers Squibb Company Overview List 4.2.2 Bristol-Myers Squibb Company Products & Services 4.2.3 Bristol-Myers Squibb Company Business Operation Conditions Table Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.3 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.) 4.3.1 F. Hoffmann-La Roche Ltd. Profile Table F. Hoffmann-La Roche Ltd. Overview List 4.3.2 F. Hoffmann-La Roche Ltd. Products & Services 4.3.3 F. Hoffmann-La Roche Ltd. Business Operation Conditions Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.4 Eli Lilly and Company (Company Profile, Sales Data etc.) 4.4.1 Eli Lilly and Company Profile Table Eli Lilly and Company Overview List 4.4.2 Eli Lilly and Company Products & Services 4.4.3 Eli Lilly and Company Business Operation Conditions Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.5 Johnson & Johnson Private Limited (Company Profile, Sales Data etc.) 4.5.1 Johnson & Johnson Private Limited Profile Table Johnson & Johnson Private Limited Overview List 4.5.2 Johnson & Johnson Private Limited Products & Services 4.5.3 Johnson & Johnson Private Limited Business Operation Conditions Table Business Operation of Johnson & Johnson Private Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.6 GlaxoSmithKline plc. (Company Profile, Sales Data etc.) 4.6.1 GlaxoSmithKline plc. Profile Table GlaxoSmithKline plc. Overview List 4.6.2 GlaxoSmithKline plc. Products & Services 4.6.3 GlaxoSmithKline plc. Business Operation Conditions Table Business Operation of GlaxoSmithKline plc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.7 Celgene Corporation (Company Profile, Sales Data etc.) 4.7.1 Celgene Corporation Profile Table Celgene Corporation Overview List 4.7.2 Celgene Corporation Products & Services 4.7.3 Celgene Corporation Business Operation Conditions Table Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.8 Pfizer Inc. (Company Profile, Sales Data etc.) 4.8.1 Pfizer Inc. Profile Table Pfizer Inc. Overview List 4.8.2 Pfizer Inc. Products & Services 4.8.3 Pfizer Inc. Business Operation Conditions Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.9 Sanofi (Company Profile, Sales Data etc.) 4.9.1 Sanofi Profile Table Sanofi Overview List 4.9.2 Sanofi Products & Services 4.9.3 Sanofi Business Operation Conditions Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.10 Novartis AG (Company Profile, Sales Data etc.) 4.10.1 Novartis AG Profile Table Novartis AG Overview List 4.10.2 Novartis AG Products & Services 4.10.3 Novartis AG Business Operation Conditions Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 5 Market Competition 5.1 Company Competition Table Global Gastrointestinal Cancer Drugs Sales Revenue 2016-2020, by Company, in USD Million Table Global Gastrointestinal Cancer Drugs Sales Revenue Share 2016-2020, by Company, in USD Million Figure Global Gastrointestinal Cancer Drugs Sales Revenue Share in 2020, by Company, in USD Million Table Global Gastrointestinal Cancer Drugs Sales Volume 2016-2020, by Company, in Volume Table Global Gastrointestinal Cancer Drugs Sales Volume Share 2016-2020, by Company, in Volume Figure Global Gastrointestinal Cancer Drugs Sales Volume Share in 2020, by Company, in Volume 5.2 Regional Market by Company Figure North America Gastrointestinal Cancer Drugs Market Concentration, in 2020 Figure Europe Gastrointestinal Cancer Drugs Market Market Concentration, in 2020 Figure Asia-Pacific Gastrointestinal Cancer Drugs MMarket Concentration, in 2020 Figure South America Gastrointestinal Cancer Drugs Market Concentration, in 2020 Figure Middle East & Africa Gastrointestinal Cancer Drugs Market Concentration, in 2020 6 Demand by End Market 6.1 Demand Situation 6.1.1 Demand in Hospitals Figure Gastrointestinal Cancer Drugs Demand in Hospitals, 2016-2020, in USD Million Figure Gastrointestinal Cancer Drugs Demand in Hospitals, 2016-2020, in Volume 6.1.2 Demand in Specialized Cancer Treatment Centers Figure Gastrointestinal Cancer Drugs Demand in Specialized Cancer Treatment Centers, 2016-2020, in USD Million Figure Gastrointestinal Cancer Drugs Demand in Specialized Cancer Treatment Centers, 2016-2020, in Volume 6.1.3 Demand in Clinics Figure Gastrointestinal Cancer Drugs Demand in Clinics, 2016-2020, in USD Million Figure Gastrointestinal Cancer Drugs Demand in Clinics, 2016-2020, in Volume 6.1.4 Demand in Ambulatory Surgical Centers Figure Gastrointestinal Cancer Drugs Demand in Ambulatory Surgical Centers, 2016-2020, in USD Million Figure Gastrointestinal Cancer Drugs Demand in Ambulatory Surgical Centers, 2016-2020, in Volume 6.2 Regional Demand Comparison Table Regional Demand Comparison List Table Major Application in Different Regions 6.3 Demand Forecast Table Gastrointestinal Cancer Drugs Demand Forecast 2021-2026, by Application, in USD Million Figure Gastrointestinal Cancer Drugs Market Growth 2021-2026, by Application, in USD Million Figure Gastrointestinal Cancer Drugs Market Share in 2026, by Application, in USD Million Table Gastrointestinal Cancer Drugs Demand Forecast 2021-2026, by Application, in Volume Table Gastrointestinal Cancer Drugs Market Growth 2021-2026, by Application, in Volume Table Gastrointestinal Cancer Drugs Market Share in 2026, by Application, in Volume 6.4 Impact of the COVID-19 on the Demand 7 Region Operation 7.1 Regional Production Table Gastrointestinal Cancer Drugs Production 2016-2020, by Region, in USD Million Table Gastrointestinal Cancer Drugs Production 2016-2020, by Region, in Volume 7.2 Regional Market Table Global Gastrointestinal Cancer Drugs Market 2016-2020, by Region, in USD Million Table Global Gastrointestinal Cancer Drugs Market Share 2016-2020, by Region, in USD Million Table Global Gastrointestinal Cancer Drugs Market 2016-2020, by Region, in Volume Table Global Gastrointestinal Cancer Drugs Market Share 2016-2020, by Region, in Volume 7.3 by Region 7.3.1 North America 7.3.1.1 Overview Figure North America Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in USD Million Figure North America Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in Volume 7.3.1.2 by Country (U.S., Canada, Mexico) Table North America Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million Table North America Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume 7.3.2 Europe 7.3.2.1 Overview Figure Europe Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in USD Million Figure Europe Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in Volume 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.) Table Europe Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million Table Europe Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume 7.3.3 Asia-Pacific 7.3.3.1 Overview Figure Asia-Pacific Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in USD Million Figure Asia-Pacific Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in Volume 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.) Table Asia-Pacific Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million Table Asia-Pacific Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume 7.3.4 South America 7.3.4.1 Overview Figure South America Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in USD Million Figure South America Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in Volume 7.3.4.2 by Country (Brazil, Argentina etc.) Table South America Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million Table South America Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume 7.3.5 Middle East & Africa 7.3.5.1 Overview Figure Middle East & Africa Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in USD Million Figure Middle East & Africa Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in Volume 7.3.5.2 by Country (Saudi Arabia, South Africa etc.) Table Middle East & Africa Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million Table Middle East & Africa Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume 7.4 Regional Import & Export 7.5 Regional Forecast Table Gastrointestinal Cancer Drugs Market Forecast 2021-2026, by Region, in USD Million Table Gastrointestinal Cancer Drugs Market Forecast 2021-2026, by Region, in Volume 8 Marketing & Price 8.1 Price and Margin 8.1.1 Price Trends 8.1.2 Factors of Price Change Table Price Factors List 8.1.3 Manufacturers Gross Margin Analysis 8.2 Marketing Channel Figure Marketing Channels Overview 9 Research Conclusion
                
List of Table List of Table 1. Table Upstream Segment of Gastrointestinal Cancer Drugs 2. Table Application Segment of Gastrointestinal Cancer Drugs 3. Table Global Gastrointestinal Cancer Drugs Market 2016-2026, by Application, in USD Million 4. Table Major Company List of Radiology 5. Table Major Company List of Others 6. Table Global Gastrointestinal Cancer Drugs Market 2016-2020, by Type, in USD Million 7. Table Global Gastrointestinal Cancer Drugs Market 2016-2020, by Type, in Volume 8. Table Global Gastrointestinal Cancer Drugs Market Forecast 2021-2026, by Type, in USD Million 9. Table Global Gastrointestinal Cancer Drugs Market Forecast 2021-2026, by Type, in Volume 10. Table Amgen Limited & Amgen Ireland Limited Overview List 11. Table Business Operation of Amgen Limited & Amgen Ireland Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 12. Table Bristol-Myers Squibb Company Overview List 13. Table Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 14. Table F. Hoffmann-La Roche Ltd. Overview List 15. Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 16. Table Eli Lilly and Company Overview List 17. Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 18. Table Johnson & Johnson Private Limited Overview List 19. Table Business Operation of Johnson & Johnson Private Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 20. Table GlaxoSmithKline plc. Overview List 21. Table Business Operation of GlaxoSmithKline plc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 22. Table Celgene Corporation Overview List 23. Table Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 24. Table Pfizer Inc. Overview List 25. Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 26. Table Sanofi Overview List 27. Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 28. Table Novartis AG Overview List 29. Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 30. Table Global Gastrointestinal Cancer Drugs Sales Revenue 2016-2020, by Company, in USD Million 31. Table Global Gastrointestinal Cancer Drugs Sales Revenue Share 2016-2020, by Company, in USD Million 32. Table Global Gastrointestinal Cancer Drugs Sales Volume 2016-2020, by Company, in Volume 33. Table Global Gastrointestinal Cancer Drugs Sales Volume Share 2016-2020, by Company, in Volume 34. Table Regional Demand Comparison List 35. Table Major Application in Different Regions 36. Table Gastrointestinal Cancer Drugs Demand Forecast 2021-2026, by Application, in USD Million 37. Table Gastrointestinal Cancer Drugs Demand Forecast 2021-2026, by Application, in Volume 38. Table Gastrointestinal Cancer Drugs Market Growth 2021-2026, by Application, in Volume 39. Table Gastrointestinal Cancer Drugs Market Share in 2026, by Application, in Volume 40. Table Gastrointestinal Cancer Drugs Production 2016-2020, by Region, in USD Million 41. Table Gastrointestinal Cancer Drugs Production 2016-2020, by Region, in Volume 42. Table Global Gastrointestinal Cancer Drugs Market 2016-2020, by Region, in USD Million 43. Table Global Gastrointestinal Cancer Drugs Market Share 2016-2020, by Region, in USD Million 44. Table Global Gastrointestinal Cancer Drugs Market 2016-2020, by Region, in Volume 45. Table Global Gastrointestinal Cancer Drugs Market Share 2016-2020, by Region, in Volume 46. Table North America Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million 47. Table North America Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume 48. Table Europe Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million 49. Table Europe Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume 50. Table Asia-Pacific Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million 51. Table Asia-Pacific Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume 52. Table South America Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million 53. Table South America Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume 54. Table Middle East & Africa Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in USD Million 55. Table Middle East & Africa Gastrointestinal Cancer Drugs Market Size 2016-2020, by Country, in Volume 56. Table Gastrointestinal Cancer Drugs Market Forecast 2021-2026, by Region, in USD Million 57. Table Gastrointestinal Cancer Drugs Market Forecast 2021-2026, by Region, in Volume 58. Table Price Factors List
List of Figure List of Figure 1. Figure Gastrointestinal Cancer Drugs Industry Chain Structure 2. Figure Global Gastrointestinal Cancer Drugs Market Growth 2016-2020, by Type, in USD Million 3. Figure Global Gastrointestinal Cancer Drugs Market Growth 2016-2020, by Type, in Volume 4. Figure Global Gastrointestinal Cancer Drugs Sales Revenue Share in 2020, by Company, in USD Million 5. Figure Global Gastrointestinal Cancer Drugs Sales Volume Share in 2020, by Company, in Volume 6. Figure North America Gastrointestinal Cancer Drugs Market Concentration, in 2020 7. Figure Europe Gastrointestinal Cancer Drugs Market Market Concentration, in 2020 8. Figure Asia-Pacific Gastrointestinal Cancer Drugs MMarket Concentration, in 2020 9. Figure South America Gastrointestinal Cancer Drugs Market Concentration, in 2020 10. Figure Middle East & Africa Gastrointestinal Cancer Drugs Market Concentration, in 2020 11. Figure Gastrointestinal Cancer Drugs Demand in Hospitals, 2016-2020, in USD Million 12. Figure Gastrointestinal Cancer Drugs Demand in Hospitals, 2016-2020, in Volume 13. Figure Gastrointestinal Cancer Drugs Demand in Specialized Cancer Treatment Centers, 2016-2020, in USD Million 14. Figure Gastrointestinal Cancer Drugs Demand in Specialized Cancer Treatment Centers, 2016-2020, in Volume 15. Figure Gastrointestinal Cancer Drugs Demand in Clinics, 2016-2020, in USD Million 16. Figure Gastrointestinal Cancer Drugs Demand in Clinics, 2016-2020, in Volume 17. Figure Gastrointestinal Cancer Drugs Demand in Ambulatory Surgical Centers, 2016-2020, in USD Million 18. Figure Gastrointestinal Cancer Drugs Demand in Ambulatory Surgical Centers, 2016-2020, in Volume 19. Figure Gastrointestinal Cancer Drugs Market Growth 2021-2026, by Application, in USD Million 20. Figure Gastrointestinal Cancer Drugs Market Share in 2026, by Application, in USD Million 21. Figure North America Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in USD Million 22. Figure North America Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in Volume 23. Figure Europe Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in USD Million 24. Figure Europe Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in Volume 25. Figure Asia-Pacific Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in USD Million 26. Figure Asia-Pacific Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in Volume 27. Figure South America Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in USD Million 28. Figure South America Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in Volume 29. Figure Middle East & Africa Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in USD Million 30. Figure Middle East & Africa Gastrointestinal Cancer Drugs Market Size and Growth 2016-2020, in Volume 31. Figure Marketing Channels Overview

Purchase Report

Single User 2980
Multi User 5960
Corporate User 5960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.